On June 11, 2025, Ocular Therapeutix, Inc. held its Annual Meeting where stockholders approved significant amendments to its stock incentive and employee purchase plans, allowing for the issuance of up to 10.75 million additional shares. This is a significant positive event as it reflects stockholder support for the company’s growth strategies.